Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes

Eur J Hum Genet. 2000 Jan;8(1):75-8. doi: 10.1038/sj.ejhg.5200400.

Abstract

The SLC6A4 gene encodes the serotonin transporter, the target of an important class of antidepressant drugs (serotonin selective reuptake inhibitors). Polymorphisms in the SLC6A4 gene have been reported to be associated with susceptibility to depression and other psychiatric disorders. We have constructed a 1 Mb YAC and PAC contig which harbours both the SLC6A4 and the carboxypeptidase D (CPD) genes. The order of loci within the contig was cen-D17S975-D17S1549-24R-D17S1294-SLC6A4-28L+ ++-(CPD, D17S2009, D17S2004)-D17S2120-ter. Both genes were deleted in one of 17 neurofibromatosis type 1 (NF1) patients carrying submicroscopic NF1 contiguous gene deletions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carboxypeptidases / genetics*
  • Carrier Proteins / genetics*
  • Chromosomes, Artificial, Yeast
  • Chromosomes, Human, Pair 17*
  • Contig Mapping
  • Humans
  • Hybrid Cells
  • In Situ Hybridization, Fluorescence
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins*
  • Nerve Tissue Proteins / genetics*
  • Neurofibromin 1
  • Proteins / genetics*
  • Serotonin / genetics*
  • Serotonin Plasma Membrane Transport Proteins
  • Telomere

Substances

  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Neurofibromin 1
  • Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin
  • Carboxypeptidases
  • carboxypeptidase D